Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: RLFTD ) N/A UNCHANGED Last Price Updated: 3:36 PM EST, Nov 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 6.250 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update September 15, 2023 Via ACCESSWIRE Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics August 30, 2023 Via ACCESSWIRE Performance More News Read More Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle East June 23, 2023 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement June 23, 2023 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders June 20, 2023 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement June 16, 2023 Via ACCESSWIRE Relief Therapeutics Announces Executive Leadership Team Changes December 08, 2022 Via ACCESSWIRE Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil) November 07, 2022 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders May 26, 2023 Via ACCESSWIRE Relief Therapeutics Announces Issuance of Shares from Authorized Capital December 13, 2022 Via ACCESSWIRE APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival November 21, 2022 Via ACCESSWIRE Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission November 16, 2022 Via ACCESSWIRE Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate November 14, 2022 Via Benzinga Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements November 14, 2022 Via ACCESSWIRE Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. Further Extend their Stay of Pending Litigation to Provide Additional Time for the Parties to Finalize their Litigation Settlement November 08, 2022 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
